| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.22B | 39.60B | 37.58B | 35.44B | 30.89B | 16.81B |
| Gross Profit | 5.23B | 3.77B | 3.73B | 4.28B | 3.10B | -1.09B |
| EBITDA | 2.29B | 3.20B | 3.07B | 3.75B | 2.93B | -732.00M |
| Net Income | 1.56B | 1.34B | 1.38B | 1.67B | 791.00M | -2.19B |
Balance Sheet | ||||||
| Total Assets | 50.70B | 49.42B | 48.16B | 46.16B | 44.26B | 43.49B |
| Cash, Cash Equivalents and Short-Term Investments | 7.70B | 8.15B | 8.49B | 8.27B | 8.30B | 7.67B |
| Total Debt | 13.02B | 14.55B | 14.23B | 13.95B | 15.17B | 16.69B |
| Total Liabilities | 38.30B | 37.71B | 36.56B | 36.45B | 35.78B | 39.00B |
| Stockholders Equity | 12.33B | 11.65B | 11.54B | 9.66B | 8.40B | 4.45B |
Cash Flow | ||||||
| Free Cash Flow | -390.00M | -737.00M | -6.00M | 659.00M | 2.66B | -700.00M |
| Operating Cash Flow | 4.32B | 3.74B | 3.89B | 4.71B | 5.17B | 618.00M |
| Investing Cash Flow | -1.88B | -3.51B | -2.33B | -2.94B | -3.44B | -3.02B |
| Financing Cash Flow | -3.07B | -850.00M | -1.45B | -2.07B | -2.27B | 2.87B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | €15.48B | 9.32 | 26.38% | 0.62% | 18.24% | 60.48% | |
67 Neutral | €53.82B | 15.37 | 16.07% | 3.97% | -2.69% | 7.84% | |
58 Neutral | €9.52B | -3.25 | 13.67% | 3.56% | 4.96% | 26.60% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
53 Neutral | €6.20B | -95.83 | 8.46% | ― | 0.92% | 2.89% | |
53 Neutral | €20.77B | -24.08 | 4.94% | 7.14% | -10.66% | -90.22% | |
52 Neutral | €3.20B | 506.40 | 13.82% | 3.86% | 6.71% | 17.83% |